Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Fatemeh Chalabianloo, Gudrun Høiseth, Jørn Henrik Vold, Kjell Arne Johansson, Marianne K. Kringen, Olav Dalgard, Christian Ohldieck, Karl Trygve Druckrey-Fiskaaen, Christer Aas, Else-Marie Løberg, Jørgen G. Bramness & Lars Thore Fadnes. (2023) Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations. Journal of Addictive Diseases 41:1, pages 53-63.
Read now
Read now
Tsung-Yu Tsai, Tzu-Yun Wang, Yu Chia Liu, Po-Wei Lee, Wei Hung Chang, Tsung-Hua Lu, Huai-Hsuan Tseng, Sheng-Yu Lee, Yun-Hsuan Chang, Yihong Yang, Po See Chen, Kao Chin Chen, Yen Kuang Yang & Ru-Band Lu. (2021) Add-on repetitive transcranial magnetic stimulation in patients with opioid use disorder undergoing methadone maintenance therapy. The American Journal of Drug and Alcohol Abuse 47:3, pages 330-343.
Read now
Read now
Signe Wegmann Düring, Julie Nordgaard & Solvej Mårtensson. (2021) Stability of admission diagnoses; data from a specialized in-patient treatment facility for dual diagnosis. Nordic Journal of Psychiatry 75:1, pages 54-62.
Read now
Read now
Gabi Koller, Andreas Schwarzer, Kathrin Halfter & Michael Soyka. (2019) Pain management in opioid maintenance treatment. Expert Opinion on Pharmacotherapy 20:16, pages 1993-2005.
Read now
Read now
Michael Soyka. (2017) Treatment of opioid dependence with buprenorphine: current update. Dialogues in Clinical Neuroscience 19:3, pages 299-308.
Read now
Read now
Daniela Krause, Diana Plörer, Gabriele Koller, Gabi Martin, Catja Winter, Roland Adam, Minavere Canolli, Jori Al-Iassin, Rainer Musselmann, Stephan Walcher, Frank Schäfer & Oliver Pogarell. (2017) High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment. Substance Use & Misuse 52:5, pages 639-645.
Read now
Read now
Michael Soyka. (2015) New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone. Substance Abuse and Rehabilitation 6, pages 1-14.
Read now
Read now
Gerardo Flórez, Ana López-Durán, Yolanda Triñanes, Jesús Osorio, Jaime Fraga, José Manuel Fernández, Elisardo Becoña & Manuel Arrojo. (2015) First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment. Neuropsychiatric Disease and Treatment 11, pages 2431-2440.
Read now
Read now
Michael Soyka. (2015) Buprenorphine–naloxone buccal soluble film for the treatment of opioid dependence: current update. Expert Opinion on Drug Delivery 12:2, pages 339-347.
Read now
Read now
Michael Soyka. (2012) Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence. Expert Opinion on Drug Delivery 9:11, pages 1409-1417.
Read now
Read now
Robert Taylor$suffix/text()$suffix/text(), Robert B Raffa & Joseph V Pergolizzi$suffix/text()$suffix/text(). (2011) Naltrexone extended-release injection: an option for the management of opioid abuse. Substance Abuse and Rehabilitation 2, pages 219-226.
Read now
Read now
Michael Soyka, Claudia Limmer, Robert Lehnert, Gabriele Koller, Gabriele Martin, Heinrich Küfner, S. Kagerer & Annina Haberthür. (2011) A Comparison of Cognitive Function in Patients under Maintenance Treatment with Heroin, Methadone, or Buprenorphine and Healthy Controls: An Open Pilot Study. The American Journal of Drug and Alcohol Abuse 37:6, pages 497-508.
Read now
Read now
Articles from other publishers (66)
Joshua B. Borris, Caitlin Dowd-Green, Lindsay A. Bowman, Suzanne A. Nesbit, Michael Fingerhood & Rosalyn W. Stewart. (2024) Evaluation of opioid use disorder treatment outcomes in patients receiving split daily versus once daily dosing of buprenorphine-naloxone. Journal of Substance Use and Addiction Treatment 156, pages 209209.
Crossref
Crossref
Tzu-Yun Wang, Ru-Band Lu, Sheng-Yu Lee, Yun-Hsuan Chang, Shiou-Lan Chen, Tsung-Yu Tsai, Huai-Hsuan Tseng, Po See Chen, Kao Chin Chen, Yen Kuang Yang & Jau-Shyong Hong. (2023) Association Between Inflammatory Cytokines, Executive Function, and Substance Use in Patients With Opioid Use Disorder and Amphetamine-Type Stimulants Use Disorder. International Journal of Neuropsychopharmacology 26:1, pages 42-51.
Crossref
Crossref
Florence Thibaut. (2022) Pharmacological Treatments for Compulsive Sexual Behaviors Among Offending Individuals. Current Addiction Reports 10:1, pages 52-59.
Crossref
Crossref
Susan L. Calcaterra, Richard Bottner, Marlene Martin, Honora Englander, Zoe M. Weinstein, Melissa B. Weimer, Eugene Lambert, Matthew V. Ronan, Sergio Huerta, Tauheed Zaman, Monish Ullal, Alyssa F. Peterkin, Kristine Torres‐Lockhart, Megan Buresh, Meghan T. O'Brien, Hannah Snyder & Shoshana J. Herzig. (2022) Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. Journal of Hospital Medicine 17:9, pages 679-692.
Crossref
Crossref
Stijn Veldman, Maria van Beek, Steffie van Rijswijk, Hannah Ellerbroek, Hans Timmerman, Selina van der Wal, Monique Steegers & Arnt Schellekens. (2022) Effects of opioid rotation to buprenorphine/naloxone on pain, pain thresholds, pain tolerance, and quality of life in patients with chronic pain and opioid use disorder. Pain 163:5, pages 955-963.
Crossref
Crossref
Fatemeh Chalabianloo, Lars Thore Fadnes, Gudrun Høiseth, Christian Ohldieck, Jørn Henrik Vold, Christer Aas, Else-Marie Løberg, Kjell Arne Johansson & Jørgen G. Bramness. (2021) Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Penghui Cao, Zhaohua Zhang, Jun Zhong, Shichao Xu, Qiaofang Huang & Ni Fan. (2021) Effects of treatment status and life quality on anxiety in MMT patients. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Abuzar Watan Pal, Zoriah Aziz & Adeeba Kamarulzaman. (2021) Methodological quality of guidelines for the management of opioid use disorder: A systematic review. Journal of Clinical Pharmacy and Therapeutics 46:6, pages 1531-1548.
Crossref
Crossref
Kirsten Lehmann, Silke Kuhn, Cinzia Baschirotto, Britta Jacobsen, Stephan Walcher, Herbert Görne, Markus Backmund, Norbert Scherbaum, Jens Reimer & Uwe Verthein. (2021) Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine. Journal of Substance Abuse Treatment 127, pages 108350.
Crossref
Crossref
Omron Hassan, Sheshanna Phan, Nicole Wiecks, Christian Joaquin & Vladimir Bondarenko. (2020) Outcomes of deep brain stimulation surgery for substance use disorder: a systematic review. Neurosurgical Review 44:4, pages 1967-1976.
Crossref
Crossref
Morgane Guillou-Landreat, Philippe Levassor, Marylène Guerlais, Veronique Sebille & Caroline Victorri-Vigneau. (2021) Prospective Study on Factors Associated with Referral of Patients with Opioid Maintenance Therapy from Specialized Addictive Disorders Centers to Primary Care. International Journal of Environmental Research and Public Health 18:11, pages 5749.
Crossref
Crossref
Mariangela Antonelli, Liana Fattore, Luisa Sestito, Daniela Di Giuda, Marco Diana & Giovanni Addolorato. (2021) Transcranial Magnetic Stimulation: A review about its efficacy in the treatment of alcohol, tobacco and cocaine addiction. Addictive Behaviors 114, pages 106760.
Crossref
Crossref
Cinzia Baschirotto, Kirsten Lehmann, Silke Kuhn, Jens Reimer & Uwe Verthein. (2020) Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care. Journal of Pharmacological Sciences 144:1, pages 9-15.
Crossref
Crossref
Kai Yuan, Lu Cao, Yan‐Xue Xue, Yi‐Xiao Luo, Xiao‐Xing Liu, Fan‐Ni Kong, Serik Tabarak, Fan Liao, Shi‐Qiu Meng, Ying Han, Ping Wu, Yan‐Ping Bao, Wen Zhang, Lin Lu & Jie Shi. (2019) Basolateral amygdala is required for reconsolidation updating of heroin‐associated memory after prolonged withdrawal. Addiction Biology 25:4.
Crossref
Crossref
Nuria Martínez & María-Consuelo Pintado. 2020. Oncologic Critical Care. Oncologic Critical Care
1913
1933
.
Paul J. Joudrey, Maria R. Khan, Emily A. Wang, Joy D. Scheidell, E. Jennifer Edelman, D. Keith McInnes & Aaron D. Fox. (2019) A conceptual model for understanding post-release opioid-related overdose risk. Addiction Science & Clinical Practice 14:1.
Crossref
Crossref
Ru-Band Lu, Tzu-Yun Wang, Sheng-Yu Lee, Shiou-Lan Chen, Yun-Hsuan Chang, Po See Chen, Shih-Hsien Lin, Chun-Hsien Chu, San-Yuan Huang, Nian-Sheng Tzeng, I Hui Lee, Kao Chin Chen, Yen Kuang Yang, Ping Chen, Shih-Heng Chen & Jau-Shyong Hong. (2019) Correlation between interleukin-6 levels and methadone maintenance therapy outcomes. Drug and Alcohol Dependence 204, pages 107516.
Crossref
Crossref
Fatemeh Chalabianloo, Andreas A. Westin, Eirik Skogvoll, Jørgen G. Bramness & Olav Spigset. (2019) Methadone serum concentrations and influencing factors: A naturalistic observational study. Psychopharmacology 236:11, pages 3159-3167.
Crossref
Crossref
Joseph V. PergolizziJr.Jr., Hani Annabi, Christopher Gharibo & Jo Ann LeQuang. (2018) The Role of Lofexidine in Management of Opioid Withdrawal. Pain and Therapy 8:1, pages 67-78.
Crossref
Crossref
Xiaoqiang Wang, Yantao Liu, Xiaozhi Wu, Yan Zhang, RuiRui Pan, Weifeng Yu & Feixiang Wu. (2019) Engineered endomorphin-2 gene: A novel therapy for improving morphine reinstatement in CPP model of rats by using deficient adenovirus as the vector. Biochemical and Biophysical Research Communications 513:1, pages 141-146.
Crossref
Crossref
Sabine Kagerer-Volk. 2019. Suchtmedizin. Suchtmedizin
385
396
.
Marc Walter & Michael Soyka. 2019. Suchtmedizin. Suchtmedizin
177
201
.
Michael Soyka. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
179
187
.
Nuria Martínez & María-Consuelo Pintado. 2019. Oncologic Critical Care. Oncologic Critical Care
1
21
.
Melike Küçükkarapınar, Hale Yapici Eser, Vahap Ozan Kotan, Merve Yalcinay-Inan, Rifat Tarhan & Zehra Arikan. (2018) Assessing the validity and reliability of the Turkish versions of craving beliefs and beliefs about substance use questionnaire in patients with heroin use disorder: demonstrating valid tools to assess cognition-emotion interplay. Substance Abuse Treatment, Prevention, and Policy 13:1.
Crossref
Crossref
Tzu-Yun Wang, Sheng-Yu Lee, Yun-Hsuan Chang, Shiou-Lan Chen, Po See Chen, Chun-Hsien Chu, San-Yuan Huang, Nian-Sheng Tzeng, I Hui Lee, Kao Chin Chen, Yen Kuang Yang, Shih-Heng Chen, Jau-Shyong Hong & Ru-Band Lu. (2018) Correlation of cytokines, BDNF levels, and memory function in patients with opioid use disorder undergoing methadone maintenance treatment. Drug and Alcohol Dependence 191, pages 6-13.
Crossref
Crossref
Maryam Alizadeh, Mahdi Zahedi-Khorasani, Ahmad-Reza Bandegi, Behpour Yousefi, Ali Rashidy-Pour, Hamid Reza Sameni & Hossein Miladi-Gorji. (2018) Effects of treadmill exercise on methadone withdrawal-induced locomotor sensitization and the ventral pallidum and ventral tegmental area BDNF levels in morphine withdrawn rats receiving methadone maintenance treatment. Neuroscience Letters 683, pages 33-37.
Crossref
Crossref
Maryam Alizadeh, Mahdi Zahedi-Khorasani & Hossein Miladi-Gorji. (2018) Treadmill exercise attenuates the severity of physical dependence, anxiety, depressive-like behavior and voluntary morphine consumption in morphine withdrawn rats receiving methadone maintenance treatment. Neuroscience Letters 681, pages 73-77.
Crossref
Crossref
Marianne K. Kringen, Fatemeh Chalabianloo, Jean-Paul Bernard, Jørgen G. Bramness, Espen Molden & Gudrun Høiseth. (2017) Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment. Therapeutic Drug Monitoring 39:5, pages 550-555.
Crossref
Crossref
Meng-Chang Tsai & Tiao-Lai Huang. (2017) Brain-derived neurotrophic factor (BDNF) and oxidative stress in heroin-dependent male patients undergoing methadone maintenance treatment. Psychiatry Research 249, pages 46-50.
Crossref
Crossref
Michael Soyka, Jens Strehle, Jürgen Rehm, Gerhard Bühringer & Hans-Ulrich Wittchen. (2017) Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample. European Addiction Research 23:2, pages 97-105.
Crossref
Crossref
Tomislav Majić, Thorsten Kienast, Andreas Heinz & Michael Soyka. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1521
1570
.
Michael Soyka & Jochen Mutschler. (2016) Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 70, pages 148-161.
Crossref
Crossref
. (2016) When treating pregnant women with opioid use disorder, the benefits of using opioid maintenance treatment outweigh the risks. Drugs & Therapy Perspectives 32:5, pages 186-190.
Crossref
Crossref
Xavier Laqueille. (2016) La pratique clinique des traitements de substitution à l’héroïne et les alternatives. Bulletin de l'Académie Nationale de Médecine 200:4-5, pages 807-818.
Crossref
Crossref
Michael Soyka. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
603
607
.
M.T. Bobes-Bascarán, M.T. Bascarán, S. Al-Halabí, P.A. Saiz, M. Bousoño, M.P. García-Portilla & J. Bobes. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
595
602
.
Tomislav Majić, Thorsten Kienast, Andreas Heinz & Michael Soyka. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
51
.
Christine M. Wilder & Theresa Winhusen. (2015) Pharmacological Management of Opioid Use Disorder in Pregnant Women. CNS Drugs 29:8, pages 625-636.
Crossref
Crossref
S.-Y. Lee, S.-L. Chen, Y.-H. Chang, C.-H. Chu, S.-H. Chen, P. S. Chen, S.-Y. Huang, N.-S. Tzeng, L.-J. Wang, I. H. Lee, T.-Y. Wang, K. C. Chen, Y. K. Yang, J.-S. Hong & R.-B. Lu. (2015) A Placebo-Controlled Trial of Dextromethorphan as an Adjunct in Opioid-Dependent Patients Undergoing Methadone Maintenance Treatment. International Journal of Neuropsychopharmacology 18:7, pages pyv008-pyv008.
Crossref
Crossref
Luis Falcato, Thilo Beck, Jens Reimer & Uwe Verthein. (2015) Self-Reported Cravings for Heroin and Cocaine During Maintenance Treatment With Slow-Release Oral Morphine Compared With Methadone. Journal of Clinical Psychopharmacology 35:2, pages 150-157.
Crossref
Crossref
Michael Soyka. (2015) Alcohol Use Disorders in Opioid Maintenance Therapy: Prevalence, Clinical Correlates and Treatment. European Addiction Research 21:2, pages 78-87.
Crossref
Crossref
Wenyuan Yin, Lin Pang, Xiaobin Cao, Jennifer M. McGoogan, Michael Liu, Congbin Zhang, Zhijun Li, Jianhua Li & Keming Rou. (2015) Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Addiction 110, pages 51-60.
Crossref
Crossref
Michael Soyka & Heinz Grunze. 2015. Co-occurring Addictive and Psychiatric Disorders. Co-occurring Addictive and Psychiatric Disorders
279
306
.
Patrizia Maria Carrieri, Laurent Michel, Caroline Lions, Julien Cohen, Muriel Vray, Marion Mora, Fabienne Marcellin, Bruno Spire, Alain Morel & Perrine Roux. (2014) Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville). PLoS ONE 9:11, pages e112328.
Crossref
Crossref
Michael Soyka, Markus Backmund, Peggy Schmidt & Sabine Apelt. (2014) Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: Results from a 12-month observational study. The American Journal on Addictions 23:6, pages 563-569.
Crossref
Crossref
M. Soyka, S. Dittert, S. Kagerer-Volk & M. Soyka. (2014) Fahrtauglichkeit bei Abhängigkeitserkrankungen und SchizophrenieDriving ability with alcohol and drug dependence and schizophrenia. Der Nervenarzt 85:7, pages 816-821.
Crossref
Crossref
Shih-Ku Lin. (2014) Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature. British Journal of Clinical Pharmacology 77:2, pages 242-252.
Crossref
Crossref
Maria Paz Garcia-Portilla, Maria Teresa Bobes-Bascaran, Maria Teresa Bascaran, Pilar Alejandra Saiz & Julio Bobes. (2014) Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?. British Journal of Clinical Pharmacology 77:2, pages 272-284.
Crossref
Crossref
Michael Soyka & Thomas Hillemacher. (2014)
Commentary on Hser
et al
. (2014): To retain or not to retain-open questions in opioid maintenance therapy
. Addiction 109:1, pages 88-89.
Crossref
Crossref
Michael Soyka, Lynn Peters, Peggy Schmidt & Annina Haberthür. (2013) Comparison of cognitive functioning in abstinent opiate-dependent individuals, methadone-maintenance patients and healthy controls: study protocol and update of the existing literature. Neuropsychiatry 3:6, pages 611-620.
Crossref
Crossref
Debasish Basu. (2013)
Commentary on Rosenthal
et al
. (2013): Buprenorphine implant-new hopes, old questions
. Addiction 108:12, pages 2150-2151.
Crossref
Crossref
Richard N. Rosenthal, Walter Ling, Paul Casadonte, Frank Vocci, Genie L. Bailey, Kyle Kampman, Ashwin Patkar, Steven Chavoustie, Christine Blasey, Stacey Sigmon & Katherine L. Beebe. (2013) Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone. Addiction 108:12, pages 2141-2149.
Crossref
Crossref
G. Vallecillo, S. Mojal, A. Roquer, D. Martinez, P. Rossi, F. Fonseca, R. Muga & M. Torrens. (2013) Risk of QTc Prolongation in a Cohort of Opioid-Dependent HIV-Infected Patients on Methadone Maintenance Therapy. Clinical Infectious Diseases 57:8, pages 1189-1194.
Crossref
Crossref
Enwu Liu, Keming Rou, Jennifer M. McGoogan, Lin Pang, Xiaobin Cao, Changhe Wang, Wei Luo, Sheena G. Sullivan, Julio S.G. Montaner, Marc Bulterys, Roger Detels & Zunyou Wu. (2013) Factors Associated With Mortality of HIV-Positive Clients Receiving Methadone Maintenance Treatment in China. The Journal of Infectious Diseases 208:3, pages 442-453.
Crossref
Crossref
Michael Soyka. (2013) Buprenorphine Use in Pregnant Opioid Users: A Critical Review. CNS Drugs 27:8, pages 653-662.
Crossref
Crossref
Marica Ferri, Silvia Minozzi, Alessandra Bo & Laura Amato. (2013) Slow-release oral morphine as maintenance therapy for opioid dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
María Torrecilla, Irrintzi Fernández-Aedo, Aurora Arrue, Mercedes Zumarraga & Luisa Ugedo. (2013) Role of GIRK channels on the noradrenergic transmission in vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice. International Journal of Neuropsychopharmacology 16:5, pages 1093-1104.
Crossref
Crossref
Ulrich Frischknecht, Derik Hermann, Milena Heinrich, Mareen Hoerst, Wolfgang Weber-Fahr, Sabine Vollstädt-Klein, Falk Kiefer, Karl Mann & Gabriele Ende. (2012) Experience of social discrimination correlates with neurometabolism: a pilot study in heroin addicts. European Archives of Psychiatry and Clinical Neuroscience 263:3, pages 197-203.
Crossref
Crossref
Jianhua LiChanghe WangJennifer M McGooganKeming RouMarc BulterysZunyou Wu. (2013) Human resource development and capacity-building during China’s rapid scale-up of methadone maintenance treatment services. Bulletin of the World Health Organization 91:2, pages 130-135.
Crossref
Crossref
Jose Martinez-Raga, Francisco Gonzalez-Saiz, Julian Oñate, Itziar Oyagüez, Eliazar Sabater & Miguel A Casado. (2012) Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain. Health Economics Review 2:1.
Crossref
Crossref
Peggy Compton, Catherine P. Canamar, Maureen Hillhouse & Walter Ling. (2012) Hyperalgesia in Heroin Dependent Patients and the Effects of Opioid Substitution Therapy. The Journal of Pain 13:4, pages 401-409.
Crossref
Crossref
Pietro Marini, Luca Romanelli, Daniela Valeri, Maria Grazia Cascio, Paolo Tucci, Pacifico Valeri & Maura Palmery. (2012) Biphasic regulation of the acute μ-withdrawal and CCk-8 contracture responses by the ORL-1 system in guinea pig ileum. Pharmacological Research 65:1, pages 100-110.
Crossref
Crossref
David Knoppert. (2011) The Worldwide Opioid Epidemic. Pediatric Drugs 13:5, pages 277-279.
Crossref
Crossref
Elizabeth M. Oliva, Natalya C. Maisel, Adam J. Gordon & Alex H. S. Harris. (2011) Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome Them. Current Psychiatry Reports 13:5, pages 374-381.
Crossref
Crossref
T. Kienast, A. Heinz & M. Soyka. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1371
1409
.